Anelloviruses and Cancer

Area of Science:

• Virology
• Oncology
• Immunology

Background:

• Anelloviruses are highly prevalent in the human virome, found in over 90% of healthy individuals.
• Despite their ubiquity, the specific role of anelloviruses in human health and disease, particularly cancer, remains largely unknown.
• Key anelloviruses include torque teno virus (TTV), torque teno midi virus (TTMDV), and torque teno mini virus (TTMV).

Purpose of the Study:

• To review and analyze the current epidemiological evidence on the association between anelloviruses (TTV, TTMDV, TTMV) and various cancers.
• To explore potential mechanisms by which anelloviruses might influence cancer development and progression.
• To highlight the conflicting findings in existing research and identify gaps in knowledge.

Main Methods:

• Literature review of epidemiological studies investigating anellovirus presence in cancer patients.
• Analysis of proposed molecular mechanisms for anellovirus involvement in cancer, including immune modulation and signaling pathways.
• Discussion of alternative explanations for anellovirus detection in cancer patients, such as compromised immune status.

Main Results:

• Epidemiological studies present mixed conclusions regarding the link between anelloviruses and cancer.
• Anelloviruses may potentially influence cancer through mechanisms like abnormal gene fusion, immune response modulation, and Toll-like receptor 9 (TLR9) activation.
• Conversely, anelloviruses might suppress tumors via TTV-derived apoptosis-inducing protein (TAIP) and NF-κB signaling inhibition.

Conclusions:

• The high prevalence of anelloviruses in cancer patients may be linked to immunocompromised states rather than a direct causative role.
• Further comprehensive research, including in vitro and in vivo studies, is crucial to elucidate the precise role of anelloviruses in cancer etiology and progression.
• Clarifying the anellovirus-cancer relationship is essential for understanding their impact on human health.